MODERN THROMBOLYTIC THERAPY IN MYOCARDIAL INFARCTION
Abstract
Myocardial infarction (MI) is a serious cardiological condition characterized by necrosis of the heart muscle tissue due to oxygen deprivation, which has a high mortality and morbidity worldwide. Timely access to reperfusion therapy for patients with MI is vital. Modern thrombolytic therapy is one of the most effective approaches to reduce myocardial necrosis by dissolving the thrombus and restoring blood flow in the first hours of MI.
References
1. O’Gara P., Antman E. Thrombolytic therapy in acute myocardial infarction. N Engl J Med. 1998;338:1374–1382.
2. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003;361:13–20.
3. Roffi M., Patrono C., Collet J.P., et al. 2015 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2016;37:267–315.
4. Gersh B.J., Stone G.W., White H.D., et al. Reperfusion therapy for ST-elevation myocardial infarction: current status and future directions. Lancet. 2010;376:1233–1244.
5. Armstrong P.W., Granger C.B., Adams P., et al. Fibrinolysis for acute myocardial infarction: a contemporary perspective. Circulation. 2007;116:124–132.
6. Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2008;117:296–329.
7. Ibanez B., James S., Agewall S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39:119–177.
8. Keeley E.C., Grines C.L. Fibrinolytic therapy versus primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis. JAMA. 2005;293:2126–2136.
